WCA
CLLS

Windsor Creek Advisors’s Cellectis CLLS Stock Holding History

Windsor Creek Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,004
Closed -$101K – 175
2020
Q1 		$101K Buy
+11,004
New +$164K 0.04% 158

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Windsor Creek Advisors's CLLS Position: Q2 2020 in Review

Windsor Creek Advisors sold out of Cellectis (CLLS) in Q2 2020, closing a stake of 11,004 shares — an estimated $101K sold.

Windsor Creek Advisors first reported a position in CLLS in Q1 2020 and held it in 1 quarter. The position peaked at $101K in Q1 2020. 79 funds tracked by Wall St. Rank hold CLLS as of Q2 2020.

  • Windsor Creek Advisors reported no remaining Cellectis position as of Q2 2020 after selling out during the quarter.
  • Windsor Creek Advisors sold 11,004 Cellectis shares in Q2 2020, an estimated $101K.
  • Windsor Creek Advisors first reported a position in Cellectis in Q1 2020 and held it in 1 quarter.
  • Windsor Creek Advisors's Cellectis position peaked at $101K in Q1 2020.
  • 79 funds tracked by Wall St. Rank held Cellectis as of Q2 2020.

Based on Windsor Creek Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.